The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Baptist Health has become the first health system in the state of Arkansas to participate in a clinical trial to evaluate a new treatment for advanced heart failure.

City-based Kauvery Hospital launched advanced electroanatomical mapping technology on Thursday for the treatment of complex heart rhythm disorders, including atrial fibrillation and ventricular ...

We report the case of a 17-year-old adolescent presenting with a large pineal region mass initially interpreted as a ruptured ...

BrainSpace, a medtech focused on neurological injuries and illnesses, received 501 (k) clearance from the FDA for its brain ...

98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...